New SEC Form D filing
Thetis Pharmaceuticals LLC, 2026-10-13
A new SEC Form D private-offering notice from Deep River, CT, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing Resolvin E1 based oral therapies for inflammatory diseases and cancer.
Filed 2026-10-13Filed to raise $1,000,000First money in 2026-08-13Raised so far $560,300HQ (as filed) Deep River, CTSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified thetispharma.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Navispend, Inc., 2026-10-23, $16.3M, Avon, CT
- LUCIER PHARMACEUTICALS INC, 2026-10-13, $2M, Bryan, TX
- Melange Space Technologies Corp., 2026-10-22, $1M, Glastonbury, CT
- CURADEL SURGICAL INNOVATIONS, INC., 2026-10-13, $57.5M, Bonita Springs, FL
- Moverz Studios Inc., 2026-10-22, $1M, New Milford, CT
- EpiVario Inc., 2026-10-13, $500K, Philadelphia, PA
- Julong Holding Ltd, 2026-10-13, $898K, Beijing
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.